Neutralising antibody response to oral poliovirus vaccine after primary immunisation with inactivated poliovirus vaccine

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 11, 1998, Pages 815-816

  Guerin N ^a   Bregere P ^b   Caudrelier, P ^b   Raynaud, O ^b  

^a Intl Ctr for Childhood/the Family   (France)

^b Pasteur Mérieux Connaught ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; NEUTRALIZING ANTIBODY; POLIOMYELITIS VACCINE;

ANTIBODY RESPONSE; ARTICLE; FEMALE; FRANCE; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; INFANT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POLIOMYELITIS; PRESCHOOL CHILD; PRIORITY JOURNAL;

ANTIBODIES, VIRAL; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INFANT; NEUTRALIZATION TESTS; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; VACCINES, COMBINED; VACCINES, INACTIVATED;

EID: 0345280108     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050198     Document Type: Article

References (8)

1. World Health Organization: Expanded programme on immunization: statement on poliomyelitis eradication. Weekly Epidemiological Record (1995) 70:345-347
2. Plotkin SA: Inactivated polio vaccine for the United States: a missed vaccination opportunity. Pediatric Infectious Disease Journal (1995) 14:835-839
3. Centers for Disease Control and Prevention: Poliomyelitis prevention in the United States: introduction of sequential schedule of inactivated poliovirus vaccine (IPV) followed by OPV. Recommendations of the Advisory Committee on Immunisation. Morbidity and Mortality Weekly Report (1997) 46(RR-3): 1-25
4. American Academy of Pediatrics Committee on Infectious Diseases: Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. Pediatrics (1997) 99:300-305
5. Mc Bean AM, Modlin JF: Rationale for the sequential use of inactivated poliovirus vaccine and live attenuated oral poliovirus vaccine for routine use in the United States. Pediatric Infectious Disease Journal (1987) 6:881-888
6. Faden H, Modlin JF, Thoms ML, McBean AM, Ferndon MB, Ogra PL: Comparative evaluation of immunization with live attenuated and enhanced potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. Journal of Infectious Diseases (1990) 162:1291-1297
7. Halsey NA, Blatter M, Bader B, Thoms ML, Willingham FF, O'Donovan JC, Pakula L, Berut F, Reisinger KS, Meschievitz C: Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type b/hepatitis B vaccine. Pediatric Infectious Disease Journal (1997) 16:675-679
8. Modlin JF, Halsey NA, Thomas ML, Meschievitz CK, Patriarca PA, and the Baltimore Area Polio Vaccine Study Group: Humoral and mucosal immunity in infants induced by three sequential IPV-OPV immunization schedules. Journal of Infectious Diseases (1997) 75 (Supplement 1): 228-234